Tag Archives: biotech

EPO Ruling On Inventiveness Of Drug Polymorphs

Thank you to Dr. Stefan Danner, a German and European Patent Attorney at DHS Patentanwaltsgesellschaft mbH in Munich for letting us post the current issue of the biotech IP newsletter dealing with the recent EPO decision concerning the patentability of … Continue reading

Posted in EP and UK Practice | Tagged , , , , , , , , , , | Leave a comment